Journal Home > Volume 13 , Issue 2

Lipid metabolism disorders commonly occur during menopause. Estrogen deficiency has been shown to lead to excessive energy intake and abnormal lipid metabolism in ovariectomized rats, resulting in obesity. Probiotics exhibit anti-obesity properties, and their underlying mechanism has been widely reported. In this study, we demonstrated the metabolic benefits of Lactobacillus plantarum CCFM1180 in suppressing appetite, controlling body weight, correcting obesity-induced abnormalities, enhancing liver lipid metabolism, and protecting liver function in estrogen-deficient rats. The mechanisms associated with the anti-obesity and antidyslipidemia effects of CCFM1180 on estrogen-deficient rats were clarified. The results showed that CCFM1180 dramatically reduced food intake by activating the expression of estrogen receptor alpha (ERα) and increasing the level of leptin in abdominal adipose tissue. These changes, combined with the increased butyrate concentration and recovered bile acid structure, helped enhance lipid metabolism. Additionally, CCFM1180 treatment was found to be safer than exogenous estrogen supplementation. Thus, L. plantarum CCFM1180 could be considered a new therapeutic strategy for preventing and alleviating menopausal lipid abnormalities.


menu
Abstract
Full text
Outline
About this article

Lactobacillus plantarum CCFM1180 attenuates obesity induced by estrogen deficiency by activating estrogen receptor alpha in abdominal adipose tissue and regulating gut microbiota-derived metabolites

Show Author's information Qian Chena,b,Chunxia Meia,bMin Guoa,b,c,dBotao Wanga,b,eHaiqin Chena,b,c,dJianxin Zhaoa,b,c,dGang Wanga,b,c,d( )Wei Chena,b,c
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, China
(Yangzhou) Institute of Food Biotechnology, Jiangnan University, Yangzhou 225004, China
Bloomage Biotechnology Co., Ltd., Jinan 250000, China

Peer review under responsibility of Tsinghua University Press.

Highlight

• CCFM1180 alleviates lipid abnormalities in ovariectomised rats.

• CCFM1180 enhances ERα expression and leptin level in abdominal adipose tissue.

• Anti-obesity effect of CCFM1180 associates with increasing colonic butyrate.

• CCFM1180 positively regulates the composition of BA pool in ovariectomised rats.

Abstract

Lipid metabolism disorders commonly occur during menopause. Estrogen deficiency has been shown to lead to excessive energy intake and abnormal lipid metabolism in ovariectomized rats, resulting in obesity. Probiotics exhibit anti-obesity properties, and their underlying mechanism has been widely reported. In this study, we demonstrated the metabolic benefits of Lactobacillus plantarum CCFM1180 in suppressing appetite, controlling body weight, correcting obesity-induced abnormalities, enhancing liver lipid metabolism, and protecting liver function in estrogen-deficient rats. The mechanisms associated with the anti-obesity and antidyslipidemia effects of CCFM1180 on estrogen-deficient rats were clarified. The results showed that CCFM1180 dramatically reduced food intake by activating the expression of estrogen receptor alpha (ERα) and increasing the level of leptin in abdominal adipose tissue. These changes, combined with the increased butyrate concentration and recovered bile acid structure, helped enhance lipid metabolism. Additionally, CCFM1180 treatment was found to be safer than exogenous estrogen supplementation. Thus, L. plantarum CCFM1180 could be considered a new therapeutic strategy for preventing and alleviating menopausal lipid abnormalities.

Keywords: Gut microbiota, Bile acid, Short chain fatty acid, Menopause, Ovariectomy

References(60)

[1]

Y. Ren, M. Zhang, Y. Liu, et al., Association of menopause and type 2 diabetes mellitus, Menopause 26 (2019) 325-330. https://doi.org/10.1097/GME.0000000000001200.

[2]

M. Hyvärinen, H.K. Juppi, S. Taskinen, et al., Metabolic health, menopause, and physical activity—a 4-year follow-up study, Int. J. Obes. 46 (2022) 544-554. https://doi.org/10.1038/s41366-021-01022-x.

[3]

C.J. Chang, C.H. Wu, W.J. Yao, et al., Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women, Int. J. Obes. 24 (2000) 1699-1704. https://doi.org/10.1038/sj.ijo.0801457.

[4]

K. Stamatelopoulos, M. Apostolakis, A. Augoulea, et al., Incident hypertension after menopause is mostly associated with obesity and insulin resistance, Maturitas 124 (2019) 139. https://doi.org/10.1016/j.maturitas.2019.04.089.

[5]

V. Venetsanaki, S.A. Polyzos, Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives, Curr. Vasc. Pharmacol. 17 (2019) 546-555. https://doi.org/10.2174/1570161116666180711121949.

[6]

P.C. Li, I. Tsai, C.Y. Hsu, et al., Risk of hyperlipidemia in women with hysterectomy-a retrospective cohort study in Taiwan, Sci. Rep. 8 (2018) 1-8. https://doi.org/10.1038/s41598-018-31347-z.

[7]

M. Wang, W. Gan, C. Kartsonaki, et al., Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women, Nutr. Metab. (Lond.). 19 (2022) 1-12. https://doi.org/10.1186/s12986-022-00643-x.

[8]

M.B. Sørensen, A.M. Rosenfalck, L. Højgaard, et al., Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy, Obes. Res. 9 (2001) 622-626. https://doi.org/10.1038/oby.2001.81.

[9]

P. Moccia, R. Belda-Montesinos, A. Monllor-Tormos, et al., Body weight and fat mass across the menopausal transition: hormonal modulators, Gynecol. Endocrinol. 38 (2022) 99-104. https://doi.org/10.1080/09513590.2021.2004395.

[10]

S. Della Torre, V. Benedusi, G. Pepe, et al., Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α, Nat. Commun. 12 (2021) 6883. https://doi.org/10.1038/s41467-021-27272-x.

[11]

A.L. Hevener, D.J. Clegg, F. Mauvais-Jarvis, Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome, Mol. Cell. Endocrinol. 418 (2015) 306-321. https://doi.org/10.1016/j.mce.2015.05.020.

[12]

S. Qiu, J.T. Vazquez, E. Boulger, et al., Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males, Sci. Rep. 7 (2017) 1-12. https://doi.org/10.1038/s41598-017-01937-4.

[13]

F. Guarner, G. Schaafsma, Probiotics, Int. J. Food Microbiol. 39 (1998) 237-238. https://doi.org/10.1016/S0168-1605(97)00136-0.

[14]

S. Huidrom, M.A. Beg, T. Masood, Post-menopausal osteoporosis and probiotics, Curr. Drug Targets. 22 (2021) 816-822. https://doi.org/10.2174/1389450121666201027124947.

[15]

J.E. Bisanz, S. Seney, A. McMillan, et al., A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women, PLoS One 9 (2014) e104511. https://doi.org/10.1371/journal.pone.0104511.

[16]

K. Wang, M. Liao, N. Zhou, et al., Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids, Cell Rep. 26 (2019) 222-235. https://doi.org/10.1016/j.celrep.2018.12.028.

[17]

M. Usami, M. Miyoshi, H. Yamashita, Gut microbiota and host metabolism in liver cirrhosis, World J. Gastroenterol. 21 (2015) 11597. https://doi.org/10.3748/wjg.v21.i41.11597.

[18]

M. Jones, C. Martoni, S. Prakash, Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial, Eur. J. Clin. Nutr. 66 (2012) 1234-1241. https://doi.org/10.1038/ejcn.2012.126.

[19]

J.R. Swann, E.J. Want, F.M. Geier, et al., Systemic gut microbial modulation of bile acid metabolism in host tissue compartments, Proc. Natl. Acad. Sci. U.S.A. 108 (2011) 4523-4530. https://doi.org/10.1073/pnas.1006734107.

[20]

E.E. Canfora, J.W. Jocken, E.E. Blaak, Short-chain fatty acids in control of body weight and insulin sensitivity, Nat. Rev. Endocrinol. 11 (2015) 577-591. https://doi.org/10.1038/nrendo.2015.128.

[21]

Y. Cheng, J. Liu, Z. Ling, Short-chain fatty acids-producing probiotics: a novel source of psychobiotics, Crit. Rev. Food Sci. Nutr. (2021) 1-31. https://doi.org/10.1080/10408398.2021.1920884.

[22]

Q. Chen, B. Wang, S. Wang, et al., Modulation of the gut microbiota structure with probiotics and isoflavone alleviates metabolic disorder in ovariectomized mice, Nutrients 13 (2021) 1793. https://doi.org/10.3390/nu13061793.

[23]

C. John, P. Werner, A. Worthmann, et al., A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids, J. Chromatogr. A. 1371 (2014) 184-195. https://doi.org/10.1016/j.chroma.2014.10.064.

[24]

G. Wang, Q. Chen, P. Tian, et al., Gut microbiota dysbiosis might be responsible to different toxicity caused by di-(2-ethylhexyl) phthalate exposure in murine rodents, Environ. Pollut. 261 (2020) 114164. https://doi.org/10.1016/j.envpol.2020.114164.

[25]

Q. Chen, Q. Kong, P. Tian, et al., Lactic acid bacteria alleviate di-(2-ethylhexyl) phthalate-induced liver and testis toxicity via their bio-binding capacity, antioxidant capacity and regulation of the gut microbiota, Environ. Pollut. (2022) 119197. https://doi.org/10.1016/j.envpol.2022.119197.

[26]

M.M. Witte, D. Resuehr, A.R. Chandler, et al., Female mice and rats exhibit species-specific metabolic and behavioral responses to ovariectomy, Gen. Comp. Endocrinol. 166 (2010) 520-528. https://doi.org/10.1016/j.ygcen.2010.01.006.

[27]

N. Dragano, E. Milbank, M. López, Estradiol and appetite: to eat or not to eat, Mol. Metab. 42 (2020). https://doi.org/10.1016/j.molmet.2020.101061.

[28]

Z. Zhang, X. Liang, Y. Lv, et al., Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro, J. Funct. Foods 64 (2020) 103664. https://doi.org/10.1016/j.jff.2019.103664.

[29]

S.D. Forssten, M.Z. Korczyńska, R.M. Zwijsen, et al., Changes in satiety hormone concentrations and feed intake in rats in response to lactic acid bacteria, Appetite 71 (2013) 16-21. https://doi.org/10.1016/j.appet.2013.06.093.

[30]

A. De Silva, S.R. Bloom, Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity, Gut Liver 6 (2012) 10. https://doi.org/10.5009/gnl.2012.6.1.10.

[31]

K. Wynne, S. Stanley, B. McGowan, et al., Appetite control, J. Endocrinol. 184 (2005) 291-318. https://doi.org/10.1677/joe.1.05866.

[32]

K.W. Yi, J.H. Shin, H.S. Seo, et al., Role of Estrogen Receptor-α and -β in regulating leptin expression in 3T3-L1 adipocytes, Obesity 16 (2008) 2393-2399. https://doi.org/10.1038/oby.2008.389.

[33]

M. Dieudonne, M. Leneveu, Y. Giudicelli, et al., Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens, Am. J. Physiol.-Cell Ph. 286 (2004) C655-C661. https://doi.org/10.1152/ajpcell.00321.2003.

[34]

F. Ahmed, P.G. Kamble, G. Fanni, et al., Role of estrogen and its receptors in adipose tissue glucose metabolism in pre-and postmenopausal women, J. Clin. Endocrinol. Metab. 107 (2022) e1879-e1889. https://doi.org/10.1210/clinem/dgac042.

[35]

B.T. Palmisano, L. Zhu, J.M. Stafford, Role of estrogens in the regulation of liver lipid metabolism, Sex and gender factors affecting metabolic homeostasis, diabetes and obesity. (2017) 227-256. https://doi.org/10.1007/978-3-319-70178-3_12.

[36]

A. Foryst-Ludwig, U. Kintscher, Metabolic impact of estrogen signalling through ERalpha and ERbeta, J. Steroid. Biochem. 122 (2010) 74-81. https://doi.org/10.1016/j.jsbmb.2010.06.012.

[37]

M. Mohamed, A. Abdel-Rahman, Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats, Eur. J. Endocrinol. 142 (2000) 307-314. https://doi.org/10.1530/eje.0.1420307.

[38]

H. Zhao, Z. Tian, J. Hao, et al., Extragonadal aromatization increases with time after ovariectomy in rats, Reprod. Biol. Endocrinol. 3 (2005) 1-9. https://doi.org/10.1186/1477-7827-3-6.

[39]

Y.L. Shen, L.Q. Zhang, Y. Yang, et al., Advances in the role and mechanism of lactic acid bacteria in treating obesity, Food Bioeng. (2022). https://doi.org/10.1002/fbe2.12002.

[40]

M.A. Stanislawski, D. Dabelea, L.A. Lange, et al., Gut microbiota phenotypes of obesity, NPJ Biofilms Microbi. 5 (2019) 1-9. https://doi.org/10.1038/s41522-019-0091-8.

[41]

J.A. Santos-Marcos, O.A. Rangel-Zuñiga, R. Jimenez-Lucena, et al., Influence of gender and menopausal status on gut microbiota, Maturitas 116 (2018) 43-53. https://doi.org/10.1016/j.maturitas.2018.07.008.

[42]

F. Magne, M. Gotteland, L. Gauthier, et al., The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 12 (2020) 1474. https://doi.org/10.3390/nu12051474.

[43]

S.J. Kallus, L.J. Brandt, The intestinal microbiota and obesity, J. Clin. Gastroenterol. 46 (2012) 16-24. https://doi.org/10.1097/MCG.0b013e31823711fd.

[44]

M. Ibrahim, S. Anishetty, A meta-metabolome network of carbohydrate metabolism: Interactions between gut microbiota and host, Biochem. Biophys. Res. Commun. 428 (2012) 278-284. https://doi.org/10.1016/j.bbrc.2012.10.045.

[45]

L. Crovesy, D. Masterson, E.L. Rosado, Profile of the gut microbiota of adults with obesity: a systematic review, Eur. J. Clin. Nutr. 74 (2020) 1251-1262. https://doi.org/10.1038/s41430-020-0607-6.

[46]

Q. Zeng, D. Li, Y. He, et al., Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities, Sci. Rep. 9 (2019) 1-10. https://doi.org/10.1038/s41598-019-49462-w.

[47]

H.J. Hu, S.G. Park, H.B. Jang, et al., Obesity alters the microbial community profile in Korean adolescents, PLoS One 10 (2015) e0134333. https://doi.org/10.1371/journal.pone.0134333.

[48]

M. Rau, A. Rehman, M. Dittrich, et al., Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease, United Eur. Gastroent. 6 (2018) 1496-1507. https://doi.org/10.1177/2050640618804444.

[49]

K.N. Kim, Y. Yao, S.Y. Ju, Short chain fatty acids and fecal microbiota abundance in humans with obesity: a systematic review and meta-analysis, Nutrients 11 (2019) 2512. https://doi.org/10.3390/nu11102512.

[50]

J.M. Baker, L. Al-Nakkash, M.M. Herbst-Kralovetz, Estrogen–gut microbiome axis: physiological and clinical implications, Maturitas 103 (2017) 45-53. https://doi.org/10.1016/j.maturitas.2017.06.025.

[51]

B. Yang, M. Li, S. Wang, et al., Lactobacillus ruminis alleviates DSS-induced colitis by inflammatory cytokines and gut microbiota modulation, Foods 10 (2021) 1349. https://doi.org/10.3390/foods10061349.

[52]

Z. Wang, C. Elekwachi, J. Jiao, et al., Changes in metabolically active bacterial community during rumen development, and their alteration by rhubarb root powder revealed by 16S rRNA amplicon sequencing, Front. Microbiol. 8 (2017) 159. https://doi.org/10.3389/fmicb.2017.00159.

[53]

Z. Gao, J. Yin, J. Zhang, et al., Butyrate improves insulin sensitivity and increases energy expenditure in mice, Diabetes 58 (2009) 1509-1517. https://doi.org/10.2337/db08-1637.

[54]

H. Lin, Y. An, H. Tang, et al., Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model, J. Agric. Food Chem. 67 (2019) 3624-3632. https://doi.org/10.1021/acs.jafc.9b00249.

[55]

J.Y. Chiang, Recent advances in understanding bile acid homeostasis, F1000Res. 6 (2017). https://doi.org/10.12688/f1000research.12449.1.

[56]

Y. Kiriyama, H. Nochi, Physiological role of bile acids modified by the gut microbiome, Microorganisms 10 (2021) 68. https://doi.org/10.3390/microorganisms10010068.

[57]

A. Hofmann, The enterohepatic circulation of bile acids in health and disease, Gastrointestinal Dis. 1 (1993) 127-150.

[58]

M.L. Jones, C.J. Martoni, J.G. Ganopolsky, et al., The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention, Expert Opin. Biol. Ther. 14 (2014) 467-482. https://doi.org/10.1517/14712598.2014.880420.

[59]
D.Q.H. Wang, B.A. Neuschwander-Tetri, P. Portincasa, et al., Interactions between bile acids and nuclear receptors and their effects on lipid metabolism and liver diseases, in: Hindawi, 2012. https://doi.org/10.1155/2012/560715.
DOI
[60]

H.H. Wang, M. Liu, D.J. Clegg, et al., New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation, Biochim. Biophys. Acta Bioenerg. 1791 (2009) 1037-1047. https://doi.org/10.1016/j.bbalip.2009.06.006.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 29 May 2022
Revised: 23 July 2022
Accepted: 24 August 2022
Published: 25 September 2023
Issue date: March 2024

Copyright

© 2024 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

Acknowledgements

Acknowledgment

This research was funded by the National Natural Science Foundation of China (31972052, 32021005, 31820103010), the Fundamental Research Funds for the Central Universities (JUSRP22006, JUSRP51501), the Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return